Editorial
Free Access
Modeling of substrate elimination by the liver: Has the albumin receptor model superseded the well-stirred model?
Denis J. Morgan,
D. Brian Jones,
Richard A. Smallwood M.D.,
Denis J. Morgan
Victorian College of Pharmacy Parkville, Victoria, Australia Gastroenterology Unit Department of Medicine Austin Hospital Heidelberg, Victoria, Australia
Search for more papers by this authorD. Brian Jones
Victorian College of Pharmacy Parkville, Victoria, Australia Gastroenterology Unit Department of Medicine Austin Hospital Heidelberg, Victoria, Australia
Search for more papers by this authorCorresponding Author
Richard A. Smallwood M.D.
Victorian College of Pharmacy Parkville, Victoria, Australia Gastroenterology Unit Department of Medicine Austin Hospital Heidelberg, Victoria, Australia
Gastroenterology Unit, Department of Medicine, Austin Hospital, Heidelberg, Victoria 3084, Australia===Search for more papers by this authorDenis J. Morgan,
D. Brian Jones,
Richard A. Smallwood M.D.,
Denis J. Morgan
Victorian College of Pharmacy Parkville, Victoria, Australia Gastroenterology Unit Department of Medicine Austin Hospital Heidelberg, Victoria, Australia
Search for more papers by this authorD. Brian Jones
Victorian College of Pharmacy Parkville, Victoria, Australia Gastroenterology Unit Department of Medicine Austin Hospital Heidelberg, Victoria, Australia
Search for more papers by this authorCorresponding Author
Richard A. Smallwood M.D.
Victorian College of Pharmacy Parkville, Victoria, Australia Gastroenterology Unit Department of Medicine Austin Hospital Heidelberg, Victoria, Australia
Gastroenterology Unit, Department of Medicine, Austin Hospital, Heidelberg, Victoria 3084, Australia===Search for more papers by this author
References
- 1 Cobelli C, Carson ER, Finklestein L, et al. Validation of simple and complex models in physiology and medicine. Am J Physiol 1984; 246: R259–R266.
- 2 Nies AS, Shand DG, Wilkinson GR. Altered hepatic blood flow and drug disposition. Clin Pharmacokinet 1976; 1: 135–155.
- 3 Winkler K, Keiding S, Tygstrup N. Clearance as a quantitative measure of liver function. In: The liver. Quantitative aspects of structure and function. Basel: Karger, 1973: 144–155.
- 4 Goresky CA, Bach GG, Nadeau BE. On the uptake of materials by the intact liver. The transport and net removal of galactose. J Clin Invest 1973; 52: 991–1009.
- 5 Gillette JR. Factors affecting drug metabolism. Ann NY Acad Sci 1971; 174: 43–66.
- 6 Rowland M, Benet LZ, Graham GG. Clearance concepts in pharmacokinetics. J Pharmacokinet Biopharm 1973; 1: 123–136.
- 7 Pang KS, Rowland M. Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and “parallel-tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm 1977; 5: 625–653.
- 8 Gumucio JJ, Miller DL. Functional implications of liver cell heterogeneity. Gastroenterology 1981; 80: 393–403.
- 9 Wilkinson GR, Shand DG. A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 1975; 18: 377–390.
- 10 Morgan DJ, Raymond K. Use of unbound drug concentration in blood to discriminate between two models of hepatic drug elimination. J Pharm Sci 1982; 71: 600–602.
- 11 Bass L, Robinson P, Bracken AJ. Hepatic elimination of flowing substrates: the distributed model. J Theor Biol 1978; 72: 161–184.
- 12 Johansen S, Keiding S. A family of models for the elimination of substrate in the liver. J Theor Biol 1981; 89: 549–556.
- 13 Gillette JR, Pang KS. Theoretic aspects of pharmacokinetic drug interactions. Clin Pharmacol Ther 1977; 22: 623–639.
- 14 Goresky CA, Gordon ER, Bach GG. Uptake of monohydric alcohols by liver: demonstration of a shared enzymic space. Am J Physiol 1983; 244: G198–G214.
- 15 Goresky CA, Bach GG, Rose CP. Effects of saturating metabolic uptake on space profiles and tracer kinetics. Am J Physiol 1983; 244: G215–G232.
- 16 Wagner JG, Szpunar GJ, Ferry JJ. Commentary: exact mathematical equivalence of the venous equilibration (“well-stirred”) model, the sinusoidal perfusion (“parallel-tube”) model, and a specific two compartment open model. Drug Metab Dispos 1984; 12: 385–388.
- 17 Wagner JG. Commentary: relationships among the venous equilibrium (“well-stirred”) model, the sinusoidal perfusion (“parallel-tube”) model, and a specific two-compartment open model. Drug Metab Dispos 1985; 13: 119–120.
- 18 Jansen JA. Influence of plasma protein binding kinetics on hepatic clearance assessed from a “tube” model and a “well-stirred” model. J Pharmacokinet Biopharm 1981; 9: 15–26.
- 19 Huang J, Oie S. Hepatic elimination kinetics of drugs with concentration-dependent serum protein binding. J Pharmacokinet Biopharm 1984; 12: 67–81.
- 20 Keiding S, Chiarantini E. Effect of sinusoidal perfusion on galactose elimination kinetics in perfused rat liver. J Pharmacol Exp Ther 1978; 205: 465–470.
- 21 Rowland M, Leitch D, Fleming G, et al. Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance in the isolated perfused rat liver preparation. J Pharmacokinet Biopharm 1984; 12: 129–147.
- 22 Byrne AJ, Morgan DJ, Harrison PM, et al. Variation in hepatic extraction ratio with unbound drug fraction discriminates between models of hepatic drug elimination. J Pharm Sci 1985; 74: 205–207.
- 23 Pang KS, Rowland M. Hepatic clearance of drugs II. Experimental evidence for acceptance of the “well-stirred” model and the “parallel-tube” model using lidocaine in the isolated perfused rat liver in situ preparation. J Pharmacokinet Biopharm 1977; 5: 655–679.
- 24 Ahmad AB, Bennett PN, Rowland M. Models of hepatic drug clearance: Discrimination between the “well-stirred” and “parallel-tube” models. J Pharm Pharmacol 1983; 35: 219–224.
- 25 Shand DG, Kornhauser DM, Wilkinson GR. Effects of route of administration and blood flow on hepatic drug elimination. J Pharmacol Exp Ther 1975; 195: 424–432.
- 26 Jones DB, Morgan DJ, Mihaly GW, et al. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding. J Pharmacol Exp Ther 1984; 229: 522–526.
- 27 Keiding S, Johansen S, Winkler K, et al. Michaelis-Menten kinetics of galactose elimination by the isolated perfused pig liver. Am J Physiol 1976; 230: 1302–1313.
- 28 Keiding S, Johansen S, Midtboll I, et al. Ethanol elimination kinetics in human liver and pig liver in vivo. Am J Physiol 1979; 237: E316–E324.
- 29 Keiding S, Johansen S, Winkler K. Hepatic galactose elimination kinetics in the intact pig. Scand J Clin Lab Invest 1982; 42: 253–259.
- 30 Bass L, Robinson P. How small is the functional variability of liver sinusoids. J Theor Biol 1979; 81: 761–769.
- 31 Keiding S, Priisholm K. Current models of hepatic pharmacokinetics: flow effects on kinetic constants of ethanol elimination in perfused rat liver. Biochem Pharmacol 1984; 33: 3209–3212.
- 32 Shand DG, Cotham RH, Wilkinson GR. Perfusion-limited effects of plasma drug binding on hepatic drug extraction. Life Sci 1976; 19: 125–130.
- 33 Huet PM, Villeneuve JP. Determinants of drug disposition in patients with cirrhosis. Hepatology 1983; 3: 913–918.
- 34 Melander A, McLean A. Influence of food intake on presystemic clearance of drugs. Clin Pharmacokinet 1983; 8: 286–296.
- 35 Symposium on hepatic transport kinetics. Am J Physiol 1983; 244: G571–G589; Am J Physiol 245: G1–G18.
- 36 Keiding S, Andreasen PB. Hepatic clearance measurements and pharmacokinetics. Pharmacology 1979; 19: 105–110.
- 37 Forker EL, Luxon BA. Albumin binding and hepatic uptake: the importance of model selection. J Pharm Sci 1983; 72: 1232–1233.
- 38 Goresky CA. Kinetic interpretation of hepatic multiple-indicator dilution studies. Am J Physiol 1983; 245: G1–G12.
- 39 Weisiger R, Gollan J, Ockner R. Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albuminbound substances. Science 1981; 211: 1048–1051.
- 40 Forker EL, Luxon BA. Albumin helps mediate removal of taurocholate by rat liver. J Clin Invest 1981; 67: 1517–1522.
- 41 Forker EL, Luxon BA, Snell M, et al. Effect of albumin binding on the hepatic transport of rose bengal: surface-mediated dissociation of limited capacity. J Pharmacol Exp Ther 1982; 233: 342–347.
- 42 Ockner RK, Weisiger RA, Gollan JL. Hepatic uptake of albuminbound substances: albumin receptor concept. Am J Physiol 1983; 245: G13–G18.
- 43 Colburn WA. Albumin does not mediate the removal of taurocholate by the rat liver. J Pharm Sci 1982; 71: 373–374.
- 44 Goresky CA. A linear method for determining liver sinusoidal and extravascular volume. Am J Physiol 1963; 204: 626–640.
- 45 Jones AL, Hradek GT, Renston RH, et al. Autoradiographic evidence for hepatic lobular concentration gradient of bile acid derivative. Am J Physiol 1980; 238: G233–G237.
- 46 Gumucio JJ, Miller DL, Krauss MD, et al. Transport of fluorescent compounds into hepatocytes and the resultant zonal labelling of the hepatic acinus in the rat. Gastroenterology 1981; 80: 639–646.
- 47 St Hilaire RJ, Hradek GT, Jones AL. Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high-capacity uptake system. Proc Natl Acad Sci 1983; 80: 3797–3801.
- 48 Conway JG, Kauffman FC, Ji S, et al. Rates of sulfation and glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule. Molec Pharmacol 1982; 22: 509–516.
- 49 Kashiwagi T, Lindros KO, Ji S, et al. Aldehyde dehydrogenasedependent acetaldehyde metabolism in periportal and pericentral regions of the perfused rat liver. J Pharmacol Exp Ther 1983; 224: 538–542.
- 50 Groothuis GGM, Keulemans KPT, Hardonk MJ, et al. Acinar heterogeneity in hepatic transport of dibromosulfophthalein and ouabain studied by autoradiography, normal and retrograde perfusions and computer simulation. Biochem Pharmacol 1983; 32: 3069–3078.
- 51 Gumucio DL, Gumucio JJ, Wilson JAP, et al. Albumin influences sulfobromophthalein transport by hepatocytes of each acinar zone. Am J Physiol 1984; 246: G86–G95.
- 52 Zimmerman HJ. Hepatotoxicity. New York: Appleton-Century-Crofts, 1978.
- 53 Massey ED, Butler WH. Zonal changes in the rat liver after chronic administration of phenobarbitone: an ultrastructural, morphometric and biochemical correlation. Chem Biol Interactions 1979; 24: 329–344.
- 54 Ong H, Du Souich P, Marchand C. In vivo study of propranolol and metabolite(s) disposition in rat liver. Drug Metab Dispos 1981; 9: 529–534.
- 55 Smallwood RA, Craigie A, Jones EA, et al. The delivery of newly synthesised albumin and fibrinogen to the plasma in dogs. Clin Sci 1968; 35: 35–43.
- 56 Stollman YR, Gartner U, Theilmann L, et al. Hepatic bilirubin uptake in the isolated perfused rat liver is not facilitated by albumin binding. J Clin Invest 1983; 72: 718–723.
- 57 Inoue M, Okajima K, Nagase S, et al. Plasma clearance of sulfobromophthalein and its interaction with hepatic binding proteins in normal and analbuminemic rats: is plasma albumin essential for vectorial transport of organic anions in the liver. Proc Natl Acad Sci USA 1983; 80: 7654–7658.
- 58 Jones DB, Ching MS, Smallwood RA, et al. A carrier-protein receptor is not a prerequisite for avid hepatic elimination of highly bound compounds. A study of propranolol elimination by the isolated perfused rat liver. Hepatology 1985; 5: 590–593.
- 59 Weisiger RA, Zacks CM, Smith ND, et al. Effect of albumin binding on extraction of sulfobromophthalein by perfused elasmobranch liver: evidence for dissociation limited uptake. Hepatology 1984; 4: 492–501.
